About 1 result found for searched term "ORIC-944" (0.248 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M55019 | ORIC-944 | PRC2/EED |
| ORIC-944 is a selective, orally active, allosteric inhibitor targeting the EED subunit of polycomb repressive complex 2 (PRC2). ORIC-944 is synergistic with androgen receptor pathway inhibitors (ARPIs) for the study of metastatic prostate cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
